期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 228, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jpba.2023.115323
关键词
Tegoprazan; Stress testing; LC-HRMS; LC-MSn; GC-Q-TOF-MS; NMR
This study investigated the stress testing of Tegoprazan under various conditions, including hydrolysis, oxidation, photolysis, and thermal stress. The results showed that Tegoprazan exhibits instability in acidic, alkaline, and oxidative conditions, and eight degradation products were identified. The synthesis and confirmation of DP-1, DP-2, and DP-3 were successfully achieved, and the degradation pathway of Tegoprazan was summarized. To the best of our knowledge, this is the first study on the forced degradation of Tegoprazan.
Tegoprazan is a novel orally active potassium-competitive acid blocker (P-CAB), capable of binding to the K+ binding site of H+/K+-ATPase in a reversible way to inhibit gastric acid secretion. Tegoprazan has been approved for treating acid-related diseases. In this study, stress testings of tegoprazan were performed under various conditions, including hydrolysis (acidic, alkaline, and neutral), oxidation, photolysis, and thermal stress. Tego-prazan showed instability in acidic, alkaline, and oxidative conditions. Eight degradation products (DPs) were identified. The DPs were characterized by LC-HRMS, LC-MSn, or GC-Q-TOF-MS. Meanwhile, DP-1, DP-2 and DP-3 were successfully synthesized and confirmed by NMR. The degradation pathway of tegoprazan was summarized. To the best of our knowledge, this is the first study on the forced degradation of tegoprazan.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据